Vijaya Diagnostic Centre Limited has successfully concluded its postal ballot process, with shareholders approving the appointment of two new Independent Directors through Special Resolutions passed on May 09, 2026. The resolutions, as set out in the Postal Ballot Notice dated February 13, 2026, received requisite majority approval from the company's members. The voting results and scrutinizer's report were submitted to the stock exchanges on April 11, 2026, by Chief Financial Officer Ankit Shah.

Postal Ballot Process Overview

The company dispatched the Notice of Postal Ballot electronically to all registered members on April 09, 2026, based on the list of shareholders as on the cut-off date of April 03, 2026. A total of 63,545 shareholders were on record as of the cut-off date. The e-voting window opened on Friday, April 10, 2026 at 9:00 AM (IST) and closed on Saturday, May 09, 2026 at 5:00 PM (IST). The e-voting facility was provided by KFin Technologies Limited. In compliance with applicable MCA Circulars, physical Postal Ballot Forms were not dispatched, and no physical postal ballot forms were received.

The scrutinizer for the postal ballot process was Balaramakrishna Desina, Proprietor of Balaramakrishna & Associates, Company Secretaries in Practice, Hyderabad, appointed by the Board of Directors in its meeting held on February 13, 2026. The scrutinizer's report was issued to the company on May 09, 2026.

Resolution 1: Appointment of Mr. Ravi Shankararamiah as Independent Director

The first Special Resolution pertained to the appointment of Mr. Ravi Shankararamiah (DIN: 00180746) as an Independent Director of the company. The promoter and promoter group were not interested in this resolution. The resolution was passed with requisite majority, with 99.9994% of total valid votes cast in favour.

The following table presents the detailed voting results for Resolution 1:

Summary of votes in favour (Resolution 1): 402 members cast 9,62,32,872 valid votes in favour, representing 99.9994% of total valid votes. Votes against: 12 members cast 623 valid votes against, representing 0.0006%. Invalid/Abstained/Not Voted: 5 members holding 2,033 shares.

Resolution 2: Appointment of Dr. Sasikala Paruchuri Kola as Independent Director

The second Special Resolution concerned the appointment of Dr. Sasikala Paruchuri Kola (DIN: 00129614) as an Independent Director of the company. The promoter and promoter group were not interested in this resolution either. The resolution was passed with requisite majority, with 99.9995% of total valid votes cast in favour.

The detailed voting results for Resolution 2 are as follows:

Summary of votes in favour (Resolution 2): 403 members cast 9,62,33,049 valid votes in favour, representing 99.9995% of total valid votes. Votes against: 11 members cast 444 valid votes against, representing 0.0005%. Invalid/Abstained/Not Voted: 5 members holding 2,035 shares.

Scrutinizer's Findings

Balaramakrishna Desina, in his report dated May 09, 2026, confirmed that both resolutions mentioned in the Postal Ballot Notice stand passed with the requisite majority as of Saturday, May 09, 2026, being the last date fixed for e-voting. The votes cast by members through e-voting were reconciled with records maintained by the Registrar and Transfer Agent of the company. No physical postal ballot forms were received or processed during the exercise.

Vijaya Diagnostic Centre has outlined a capital expenditure plan of ₹140-150 crore for FY27, according to the company's management during a concall update. A key highlight of this planned investment is the development of a fully automated laboratory in Hyderabad, underscoring the company's focus on upgrading its diagnostic capabilities and infrastructure.

Capital Expenditure Overview

The management's capex guidance for FY27 reflects a structured approach to expanding and modernising the company's operational footprint. The following table summarises the key details of the announced capital expenditure plan:

Strategic Focus on Automation

The planned fully automated laboratory in Hyderabad represents a significant infrastructure initiative for Vijaya Diagnostic Centre. Automation in diagnostic laboratories is aimed at enhancing throughput, improving turnaround times, and standardising testing processes. The Hyderabad facility is positioned as a central element of the company's FY27 capital deployment strategy, reflecting management's intent to strengthen its core diagnostic operations in the region.